Diagnostics Archives

sepsis diagnosis abionic blood infection

News and Trends 16 Sep 2019

Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test

A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict within just five minutes which intensive care patients are likely to develop sepsis in a clinical study. In the pivotal study, Abionic trialed the blood test in 300 intensive care patients with a high risk of sepsis. Abionic found that […]

September 16, 2019 - 3 minutesmins - By Jonathan Smith

oncimmune liquid biopsy lung cancer test

News and Trends 10 Sep 2019

Blood Test Increases Early Lung Cancer Diagnosis in UK Trial

A blood test for anti-cancer antibodies, developed by the UK diagnostics company Oncimmune, detected more early cases of lung cancer than standard clinical monitoring procedures in a trial with more than 12,000 patients. Oncimmune’s trial recruited 12,209 patients with a high risk of developing lung cancer through smoking and family history, and monitored them for […]

September 10, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Jul 2019

European Biotech: The Insider View

How has CRISPR changed drug development? How do you negotiate a good partnership? What are some of the hard decisions to make in founding a biotech? These are some of the questions that industry experts answered at Labiotech’s first Insider Day. Held exclusively for members, Labiotech’s first Insider Day aimed to explore the different aspects […]

July 7, 2019 - 10 minutesmins - By Jonathan Smith

In Depth 4 Jun 2019

Ultra-Fast Diagnostics Could Transform Sexual Health

Each day more than one million people around the world acquire sexually transmitted infections, with a profound impact on sexual and reproductive health across the globe. Biotechs across Europe are developing rapid diagnostics for some of the most common STIs. It’s difficult to comprehend the sheer scale of the number of people affected by sexually […]

June 4, 2019 - 7 minutesmins - By David Cox

News and Trends 3 Jun 2019

Belgian and US Biotechs Team up to Reduce CAR T Side Effects

The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR T-cell therapies in patients to better manage side effects. CAR T-cell therapies have revolutionized the way we treat cancer. Instead of giving the patient a classical drug, companies can inject them with living, genetically engineered cells that kill cancer cells. […]

June 3, 2019 - 3 minutesmins - By Jonathan Smith

mobidiag antibiotic resistance diagnostic

News and Trends 15 May 2019

€25M European Loan to Fund Diagnostics Tackling Antibiotic Resistance

The Finnish biotech Mobidiag has received a loan of €25M from the European Investment Bank to commercialize diagnostic technology aimed at reducing antibiotic resistance. When patients get a bacterial infection, clinicians have to wait several days for traditional diagnosis techniques to tell them what kind of bacteria is causing the infection. While they wait, the […]

May 15, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 29 Mar 2019

Liquid Biopsy for Lung Cancer Gets €46M Boost

Inivata has raised a €46M (£40M) Series B round that will further advance the commercialization of the company’s blood test for lung cancer as well as the development of new tests. Investors include Woodford patient Capital Trust, IP Group, Cambridge Innovation Capital, Johnson & Johnson Innovation and RT Ventures. Based in both the US and […]

March 29, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Next generation sequencing Nick McCooke Solexa DNA electronics

Interview 11 Mar 2019

The Man Behind Next-Generation Sequencing

Nick McCooke shares the story behind the invention of next-generation sequencing at Solexa and his latest adventure in the sequencing world with the company DNA Electronics. Nick McCooke led the pioneer team at Solexa that invented next-generation sequencing, a technology to read DNA at high speed that is nowadays used worldwide and has laid the […]

March 11, 2019 - 9 minutesmins - By Clara Rodríguez Fernández

In Depth 19 Feb 2019

How New Microbiome Diagnostic Technologies Can Save Lives

With the rise of a whole new field of research around the microbiome, what role are new technologies to identify microorganisms playing in the future of healthcare? Traditionally, microbes have been seen solely as a threat. But in the last few years, microbiome research has started to shift this view. Today, we know certain microorganisms […]

February 19, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

More News! 8 Feb 2019

Swiss Firm Launches Cancer Test That Gives Results in Minutes

Lunaphore Technologies has launched a device for automated testing of cancer tissue samples that gives results in under 30 minutes. Lunaphore has developed a piece of next-generation equipment to perform immunohistochemistry (IHC) tests, a common technique used to find specific cancer biomarkers in tissue samples from cancer patients after a biopsy. The equipment, called LabSat, will […]

February 8, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

elypta renal cell carcinoma kidney blood cancer

News and Trends 4 Feb 2019

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

The Swedish biotech Elypta has received a Horizon 2020 grant of €2.4M to fund a clinical trial of a blood and urine test that provides an accurate diagnosis of renal cell carcinoma. The clinical trial aims to validate Elypta’s technology as a monitoring tool in patients who have been treated for the kidney cancer renal […]

February 4, 2019 - 2 minutesmins - By Jonathan Smith

Interview 13 Dec 2018

Making DNA Quantification More Precise Than Ever

Technology advances are taking DNA quantification to a whole new level of precision by making it possible to identify single molecules in a sample. Philip talked to Rémi Dangla, CEO and co-founder of Stilla Technologies, to discuss advances and challenges in the field. Founded in 2013, Stilla Technologies is a French company that makes and […]

December 13, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Diagnostics

Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test

Blood Test Increases Early Lung Cancer Diagnosis in UK Trial

European Biotech: The Insider View

Ultra-Fast Diagnostics Could Transform Sexual Health

Belgian and US Biotechs Team up to Reduce CAR T Side Effects

€25M European Loan to Fund Diagnostics Tackling Antibiotic Resistance

Liquid Biopsy for Lung Cancer Gets €46M Boost

The Man Behind Next-Generation Sequencing

How New Microbiome Diagnostic Technologies Can Save Lives

Swiss Firm Launches Cancer Test That Gives Results in Minutes

Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test

Making DNA Quantification More Precise Than Ever

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!